Fred Hutchinson Cancer Research Center

• University of Washington

  PROACT: Promoting Follow-up of Abnormal Colorectal Cancer Screening Tests through Multilevel Interve (sub-award to UNIVERSITY OF WASHINGTON), usaspending_subaward/ASST_NON_R37CA295618_075/HD1WMN6945W6, US$72.6k, 2026, 17 Mar 2026

• Northwestern University

  PROACT: Promoting Follow-up of Abnormal Colorectal Cancer Screening Tests through Multilevel Interve (sub-award to NORTHWESTERN UNIVERSITY), usaspending_subaward/ASST_NON_R37CA295618_075/KG76WYENL5K1, US$46.3k, 2026, 2 Feb 2026

• Regent University

  Biomarkers for optimizing risk prediction and early detection of cancers of the colon and esophagus (sub-award to THE REGENTS OF THE UNIVERSITY OF COLORADO), usaspending_subaward/ASST_NON_U2CCA271902_075/MW8JHK6ZYEX8, US$34.3k, 2025, 4 Nov 2025

• University of North Carolina at Chapel Hill

  Biomarkers for optimizing risk prediction and early detection of cancers of the colon and esophagus (sub-award to UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL), usaspending_subaward/ASST_NON_U2CCA271902_075/D3LHU66KBLD5, US$75.4k, 2025, 30 May 2025

Sources: openalex.org

• Expanding access to colorectal cancer screening through community pharmacies: Study protocol for the PharmFITTM randomized controlled trial

  22 Aug 2026

• The pleiotropic landscape of rare variant associations with multiple cancers in large biobanks

  20 Aug 2026

Sources: api.crossref.org